Released on: December 15, 2007, 1:06 am

Press Release Author: Shushmul Maheshwari

Industry: Healthcare

Press Release Summary: Rising health consciousness, growing aging population, and
strong government initiatives will drive the growth of Russian Pharma Industry,
leading to double-digit growth rate, says the RNCOS report.

Press Release Body: RNCOS has recently released its market research report "Russian
Pharma Sector Analysis (2007)" to evaluate the factors affecting the pharmaceutical
market in Russia. The report notifies increasing aging population, rising health
consciousness in the country, medical insurance, strong government support and the
rising sales volume of expensive drugs as the key factors that will drive the
Russian pharmaceutical market during 2007-2011. On the back of these factors, the
Russian pharmaceutical industry is anticipated to increase at a CAGR of over 15%
during 2007 to 2011.

Drugs for Cancer, HIV, and Cardiovascular ailments will provide the biggest
opportunity area for the Russian pharmaceutical market in future, says the RNCOS
research. Moreover, the diabetic population of the country is also increasing
leading to heightened demand for insulin, thus forming another prospective area.

According to the report, the pharmaceutical market in Russia started experiencing
massive expansion globally in 2006, with both the commercial and state segments
posting double-digit growth in the sales value, with a major boost coming from the
drug reimbursement program of the government. It also evaluates the market segments
of the industry that mainly comprise of the state segment, commercial segment and
the Para pharmaceutical segment which have experienced exceptional growth.

The RNCOS research has find a unique trend in the Russian pharmaceutical market
where the sales of the drugs declined in terms of volume but amplified in terms of
value.

The report also specifies certain negativities which might obstruct the growth of
the Russian pharmaceutical market in future. These include huge percentage of
counterfeiting drugs, IPR protection regime and poor quality control standards.

"Russian Pharma Sector Analysis (2007)" provides a keen insight into the Russian
pharmaceutical market by systematically evaluating the emerging trends impacting the
market and thus predicts its future performance. It addresses the key opportunities
and challenges, driving factors, and impact of government policies on the
pharmaceutical market.

This research report is a work of in-depth analysis of the Russian pharmaceutical
industry, covering various market parameters like the size of pharma market,
structure of the health care sector, demographics, and a comparative analysis of the
market segments.


Web Site: http://www.rncos.com

Contact Details: RNCOS E-Services Pvt. Ltd.
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229